Standout Papers

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophospham... 2005 2026 2012 2019 561
  1. Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31 (2005)
    Elizabeth Tan-Chiu, Greg Yothers et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 29 from Science/Nature 67 standout
Sub-graph 1 of 21

Citing Papers

Mitochondrial transfer mediates endothelial cell engraftment through mitophagy
2024 StandoutNature
Co-opting signalling molecules enables logic-gated control of CAR T cells
2023 StandoutNature
3 intermediate papers

Works of Thomas E. Seay being referenced

Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08
2010
Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31
2005 Standout

Author Peers

Author Last Decade Papers Cites
Thomas E. Seay 1708 547 131 492 20 2.2k
A. Hennipman 1566 496 89 871 39 2.5k
Michael Binder 2068 242 78 802 14 2.8k
Frank A. Scappaticci 1382 466 111 842 38 2.8k
Giuseppe Fraschini 1335 898 118 301 50 2.0k
Nils‐Olof Bengtsson 1088 747 223 374 34 2.0k
Thomas A. Puchalski 1523 409 63 822 50 2.8k
H. Y. Yap 921 528 79 449 39 1.4k
Amy P. Sing 1332 735 119 420 32 1.9k
J. L. Misset 2110 556 64 1016 63 2.9k
Fabio A.B. Schutz 1384 275 73 1138 45 2.8k

All Works

Loading papers...

Rankless by CCL
2026